MOD Form 144: Planned sale of 25,173 restricted shares on NYSE
Rhea-AI Filing Summary
Form 144 notice by an insider of Modine Manufacturing Co (MOD) discloses a proposed sale of 25,173 shares of common stock, with an aggregate market value of $3,545,903.96, against 52,490,229 shares outstanding. The sale is slated for 08/22/2025 on the NYSE. The filing lists multiple tranches of restricted stock acquired from the issuer on dates between 02/18/2022 and 06/06/2025, with individual lot sizes ranging from 18 to 12,968 shares. The filer indicates no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- Planned sale fully disclosed with broker details and specific sale date (08/22/2025).
- Acquisition history provided showing restricted stock grant dates and lot sizes for transparency.
- No securities sold in the past three months, as explicitly stated in the filing.
Negative
- None.
Insights
TL;DR Routine Rule 144 notice: a proposed sale of 25,173 restricted shares valued at $3.55M on the NYSE; no recent sales reported.
This filing is a standard Rule 144 disclosure indicating an insider plans to sell restricted common shares acquired from the issuer across multiple grant dates. The filing quantifies the lot-by-lot acquisitions and shows the aggregate sale size relative to shares outstanding, which is roughly 0.048% of outstanding shares (25,173 of 52,490,229). The notice preserves transparency on timing and broker details and states no sales in the past three months. The document does not include any financial results, company operational updates, or indications of regulatory or litigation issues.
TL;DR Compliance-focused disclosure showing planned insider sale of restricted stock; form contains required representations and broker information.
The submission provides the broker name and address, the class of securities, acquisition dates and nature (restricted stock), and the planned sale date, which aligns with Rule 144 disclosure requirements. The filer affirms no undisclosed material adverse information and provides the mandatory signature/representation language. There is no indication in this form of unusual trading arrangements, clustered sales, or aggregated third-party sales that would alter governance concerns. The information is limited to the intended transaction and acquisition history.